Compass Therapeutics
CAMBRIDGE, MA · Founded 2018 · CIK 0001738021 · Biotech · Public
Therapeutic lead identification platforms using computational methods
compasstherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $256M
- 2 Form D · Jul 2020
- 75 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 15 granted · 25 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 2 same day | Form D · SEC | $60,482,210 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $195,276,780 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1997 | JYANT, INC. | — | — |
| 1998 | CERAMIDE THERAPEUTICS, LLC | — | — |
| 1999 | CLAIRIgene | — | — |
| 2000 | Compass Therapeutics | — | $256M |
| 2001 | NiKang Therapeutics | — | $200M |
| 2002 | Regulonix | — | — |
| 2003 | FORMATION VENTURE ENGINEERING FOUNDRY INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Vered Bisker-LeibExecutive Officer
- Philip FerneauDirector
- Carl GordonDirector
- Thomas SchuetzDirector · Executive Officer
- Stephen SquintoDirector
- Julie SunderlandDirector
Patents
- Multispecific Binding Constructs Against Checkpoint Molecules And Uses Thereofapplication
- Multispecific Binding Constructs Against Checkpoint Molecules And Uses Thereofgranted
- Transgenic Mouse Expressing Common Human Light Chaingranted
- Antibodies That Bind CD277 And Uses Thereofgranted
- CD137 Antibodies And PD-1 Antagonists And Uses Thereofapplication
- Method Of Treating Cancer Using CD137 Antibodies And PD-1 Antagonistsgranted
- Agonist Antibodies That Bind Human CD137 And Uses Thereofapplication
- Multispecific Binding Constructs Against Checkpoint Molecules And Uses Thereofgranted
- CD137 Antibodies And Tumor Antigen-targeting Antibodies And Uses Thereofgranted
- Agonist Antibodies That Bind Human CD137 And Uses Thereofgranted
- CD137 Antibodies And PD-1 Antagonists And Uses Thereofgranted
- Formulations Of Antibodies That Bind Human CD137 And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.